1-20 of 39
A. Hussein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Monoclonal gammopathy of thrombotic/thrombocytopenic significance

Adam J. Kanack, Jordan K. Schaefer, Meera Sridharan, Noah P. Splinter, Mindy C. Kohlhagen, Bandana Singh, Silvana B. De Lorenzo, Emily E. Mauch, Maen A. Hussein, Marwan Shaikh, Shaji Kumar, Renren Wen, Demin Wang, David Murray, Anand Padmanabhan
Journal: Blood
Blood (2023) 141 (14): 1772–1776.
https://doi.org/10.1182/blood.2022018797
Published: 2023
Includes: Supplemental data
Journal Articles

Results of a Phase I Study of Pnk-007, Allogeneic, Off the Shelf NK Cell, Post Autologous Transplant in Multiple Myeloma (NCT02955550)

Sarah A. Holstein, MD PhD, Sarah Cooley, MD, Parameswaran Hari, MBBS, MD, Sundar Jagannath, MD, Catherine R Balint, BSc, William Van Der Touw, Michele L. Donato, MD, Philip L. McCarthy, MD, Paul K. Wallace, MS, PhD, Xiaokui Zhang, PhD, Robert Hariri, MD PhD, Mohamad A. Hussein, MDMBBS, Ravi Vij, MBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 4451.
https://doi.org/10.1182/blood-2019-128467
Published: 2019
Journal Articles

Disease and Outcome Disparities in Multiple Myeloma (MM): Exploring the Role of Race/Ethnicity and Obesity in Cooperative Group Clinical Trials

Sikander Ailawadhi, MD, Susanna Joan Jacobus, MSc, Rachael Sexton, MS, A. Keith Stewart, MD, Angela Dispenzieri, MD, Mohamad A. Hussein, Jeffrey Zonder, MD, John Crowley, PhD, Antje Hoering, PhD, Bart Barlogie, MD PhD, Robert Z. Orlowski, PhD, MD, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2016) 128 (22): 1192.
https://doi.org/10.1182/blood.V128.22.1192.1192
Published: 2016
Journal Articles

Patterns of Total Costs of Care over Time for Patients with Multiple Myeloma (MM)

Steven R Arikian, Gary Binder, Craig Gibson, X Henry Hu, Yasir Nagarwala, Mohamad A. Hussein, Frank A. Corvino, Jianyi Lee, Andy Surinach, Satyin Kaura, Saad Usmani
Journal: Blood
Blood (2015) 126 (23): 3294.
https://doi.org/10.1182/blood.V126.23.3294.3294
Published: 2015
Journal Articles

Patterns of Total Costs of Care for Newly Diagnosed Multiple Myeloma (MM) Patients

Steven R. Arikian, Dejan Milentijevic, Gary Binder, Mara Silvia Monzini, X Henry Hu, Yasir Nagarwala, Mohamad A. Hussein, MD, Frank A. Corvino, Andy Surinach, Saad Z. Usmani, MD
Journal: Blood
Blood (2014) 124 (21): 2656.
https://doi.org/10.1182/blood.V124.21.2656.2656
Published: 2014
Journal Articles

Impact of Novel Treatments on Multiple Myeloma Survival

David Robinson, Satyin Kaura, MSci, MBA, Daniel Kiely, Mohamad A. Hussein, MD, Knar Nersesyan, Brian G. M. Durie, MD
Journal: Blood
Blood (2014) 124 (21): 5676.
https://doi.org/10.1182/blood.V124.21.5676.5676
Published: 2014
Journal Articles

Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997

Brief Report
Mitchell R. Smith, Donna Neuberg, Ian W. Flinn, Michael R. Grever, Hillard M. Lazarus, Jacob M. Rowe, Gordon Dewald, John M. Bennett, Elisabeth M. Paietta, John C. Byrd, Mohamad A. Hussein, Frederick R. Appelbaum, Richard A. Larson, Mark R. Litzow, Martin S. Tallman
Journal: Blood
Blood (2011) 118 (13): 3525–3527.
https://doi.org/10.1182/blood-2011-03-342485
Published: 2011
Journal Articles

Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)

Brief Report
Jeffrey A. Zonder, John Crowley, Mohamad A. Hussein, Vanessa Bolejack, Dennis F. Moore, Sr, Brock F. Whittenberger, Muneer H. Abidi, Brian G. M. Durie, Bart Barlogie
Journal: Blood
Blood (2010) 116 (26): 5838–5841.
https://doi.org/10.1182/blood-2010-08-303487
Published: 2010
Includes: Supplemental data
Journal Articles

Increased Incidence of Therapy Related Myeloid Neoplasia (t-MN) After Initial Therapy for CLL with Fludarabine-Cyclophosphamide (FC) Vs Fludarabine (F): Long-Term Follow-up of US Intergroup Study E2997

Mitchell R Smith, MD, PhD, Donna Neuberg, ScD, Ian W. Flinn, MD, PhD, Michael R. Grever, M.D., John M. Bennett, MD, Gordon Dewald, Elisabeth M Paietta, PhD, Mark R. Litzow, MD, Jacob M. Rowe, David Lucas, PhD, Shinichi Kitada, Ph.D., Diane F. Jelinek, PhD, John G. Gribben, MD, DSc, John C. Byrd, MD, John C. Reed, MD, PhD, Mohamad A. Hussein, M.D., Frederick R. Appelbaum, MD, Richard A. Larson, MD, Dennis F Moore, Jr, MD, Martin S. Tallman, MD
Journal: Blood
Blood (2010) 116 (21): 924.
https://doi.org/10.1182/blood.V116.21.924.924
Published: 2010
Journal Articles

Mature Results of MM011: A Phase I/II Trial of Lenalidomide, Liposomal Doxorubicin, Dexamethasone, and Vincristine, Followed by Lenalidomide Maintenance (DVd-R) for Relapsed or Refractory Multiple Myeloma

Aleksandr Lazaryan, MD, MPH, PhD, Rachid Baz, MD, Mohamad A Hussein, Jr, MD, Paul Elson, ScD, Beth Faiman, CNP, Becky Habecker, Mary Ann Karam, RN, Janice Reed, RN, Kimberly Hamilton, RN, Kellie Bruening, Gordan Srkalovic, MD, PhD, Steven Andresen, DO, Matt Kalaycio, MD, John William Sweetenham, MD, FRCP, Ronald Sobecks, MD, Robert Dean, MD, Robert Knight, MD, Jerome B. Zeldis, MD, PhD, Frederic J. Reu, MD
Journal: Blood
Blood (2010) 116 (21): 1967.
https://doi.org/10.1182/blood.V116.21.1967.1967
Published: 2010
Journal Articles

Updated Results of the Phase II Study of Pegylated Liposomal Doxorubicin (PLD), Low Dose Dexamethasone (DEX) and Lenalidomide (LEN) In Patients with Newly Diagnosed (ND) Multiple Myeloma (MM)

Rachid Baz, MD, Mohamad A Hussein, MD, Daniel Sullivan, MD, Jose-Leonel Ochoa-Bayona, M.D., Monique A Hartley, MD, Kenneth Shain, MD, PhD, Taiga Nishihori, MD, Jennifer Paleveda, Kara Kosakowski, William S. Dalton, PhD, MD, Melissa Alsina, MD
Journal: Blood
Blood (2010) 116 (21): 3054.
https://doi.org/10.1182/blood.V116.21.3054.3054
Published: 2010
Journal Articles

Phase I Study of Elotuzumab (HuLuc63) in Phase I Study of Elotuzumab (HuLuc63) in Relapsed/Refractory Multiple Myeloma

Jeffrey A. Zonder, Seema Singhal, William Bensinger, Ann Mohrbacher, Mohamad A. Hussein, Nikhil C. Munshi, Ingrid Caras, Anil Singhal, Frits van Rhee
Journal: Blood
Blood (2008) 112 (11): 2773.
https://doi.org/10.1182/blood.V112.11.2773.2773
Published: 2008
Journal Articles

Results of a Phase I Study of GRN163L, a Direct Inhibitor of Telomerase, in Patients with Relapsed and Refractory Multiple Myeloma (MM)

Asher Alban Chanan-Khan, MD, Nikhil C. Munshi, MD, Mohamad A. Hussein, M.D., Laurence Elias, MD, Fabio Benedetti, M.D., Jennifer Smith, Ph.D., Soo-Peang Khor, Ph.D., Carol A. Huff, MD
Journal: Blood
Blood (2008) 112 (11): 3688.
https://doi.org/10.1182/blood.V112.11.3688.3688
Published: 2008
Journal Articles

Balloon Kyphoplasty Improves Both Roland-Morris Disability Scores and Bone Pain among Cancer Patients with Vertebral Compression Fractures: Interim Analysis of Results from a Phase IV Random Trial

James R. Berenson, MD, John B Tillman, PhD, Mohamad A. Hussein, MD, Robert Pflugmacher, MD, Peter Jarzem, MD, Sami Elmoufti, MS, Frank D Vrionis, MD
Journal: Blood
Blood (2008) 112 (11): 3695.
https://doi.org/10.1182/blood.V112.11.3695.3695
Published: 2008
Journal Articles

Neuropsychological (NP) Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adult Patients with Sickle Cell Disease (SCD).

Elliott Vichinsky, J. Gold, R. Rule, M. Weiner, B. Eggleston, A. Muma, L. Neumayr, S. Lieff, D. Bessman, K. Kalinyak, L. De Castro, T. Harrington, A. Hussein, C. Johnson, L. McMahon, E. Orringer, C. Rutherford, D. Armstrong, Comprehensive Sickle Cell Centers
Journal: Blood
Blood (2007) 110 (11): 428.
https://doi.org/10.1182/blood.V110.11.428.428
Published: 2007
Journal Articles

Phase I Trial of Oral Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Combination with Bortezomib in Patients with Advanced Multiple Myeloma.

Donna M. Weber, Sundar Jagannath, Amitabha Mazumder, Ronald Sobecks, Gary J. Schiller, Maria Gavino, Chantelle Sumbler, Carrie McFadden, Cong Chen, Justin L. Ricker, Syed Rizvi, Carol Oerth, Patricia Brownell, Mohamad A. Hussein
Journal: Blood
Blood (2007) 110 (11): 1172.
https://doi.org/10.1182/blood.V110.11.1172.1172
Published: 2007
Journal Articles

Phase I Trial of HuLuc63 in Multiple Myeloma.

William Bensinger, Jeffrey Zonder, Seema Singhal, Ann Mohrbacher, Robert M. Dean, Frits van Rhee, Ahmad-Samer Al-Homsi, Nikhil C. Munshi, Edward R. Conner, Mohamad A. Hussein
Journal: Blood
Blood (2007) 110 (11): 1180.
https://doi.org/10.1182/blood.V110.11.1180.1180
Published: 2007
Journal Articles

Superiority of Lenalidomide (Len) Plus High-Dose Dexamethasone (HD) Compared to HD Alone as Treatment of Newly-Diagnosed Multiple Myeloma (NDMM): Results of the Randomized, Double-Blinded, Placebo-Controlled SWOG Trial S0232.

Jeffrey A. Zonder, MD, John Crowley, Ph.D., Mohamad A. Hussein, M.D., Vanessa Bolejack, Ph.D, Dennis F. Moore, Sr.M.D., Brock F. Whittenberger, M.D., Muneer H. Abidi, M.D., Brian G.M. Durie, M.D., Bart Barlogie, M.D.
Journal: Blood
Blood (2007) 110 (11): 77.
https://doi.org/10.1182/blood.V110.11.77.77
Published: 2007
Journal Articles

CD28-mediated regulation of multiple myeloma cell proliferation and survival

Nizar J. Bahlis, Anne M. King, Despina Kolonias, Louise M. Carlson, Hong Yu Liu, Mohamad A. Hussein, Howard R. Terebelo, Gerald E. Byrne, Jr, Bruce L. Levine, Lawrence H. Boise, Kelvin P. Lee
Journal: Blood
Blood (2007) 109 (11): 5002–5010.
https://doi.org/10.1182/blood-2006-03-012542
Published: 2007
Journal Articles

Phase-1 Study of ZIO-101: A New Organic Arsenic Active in Acute Myelogenous Leukemia (AML) and Multiple Myeloma (MM).

James R. Berenson, MD, Ralph Vincent V. Boccia, M.D., Mohamad A. Hussein, M.D., Andrew Belch, M.D., Lawrence Boise, M.D., Brian Schwartz, M.D., Robert Peter Gale, M.D.,Ph.D., Steven M. Kornblau, M.D.
Journal: Blood
Blood (2006) 108 (11): 1966.
https://doi.org/10.1182/blood.V108.11.1966.1966
Published: 2006